[{"address1": "100 Overlook Center", "address2": "Suite 102", "city": "Princeton", "state": "NJ", "zip": "08540", "country": "United States", "phone": "609 375 2227", "website": "https://www.sonnetbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 to treat chemotherapy-induced peripheral neuropathy (CIPN), and diabetic peripheral neuropathy; SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer; SON-1411, a bifunctional combination of human interleukin 18 (IL-18) inhibitor binding protein and single-chain human IL-12 (IL-12) for solid tumor cancers; and SON-1400, a monofunctional fusion protein comprising the IL-18 binding protein resistant domain linked to the FHAB. It has a license agreement with New Life Therapeutics Pte, Ltd. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6; and strategic development collaboration with Sarcoma Oncology Center to advance SON-1210. The company is headquartered in Princeton, New Jersey.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Pankaj  Mohan Ph.D.", "age": 59, "title": "Founder, Chairman, CEO & President", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 538998, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John K. Cini Ph.D.", "age": 72, "title": "Chief Scientific Officer & Co-Founder", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 397750, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.54, "open": 1.51, "dayLow": 1.48, "dayHigh": 1.55, "regularMarketPreviousClose": 1.54, "regularMarketOpen": 1.51, "regularMarketDayLow": 1.48, "regularMarketDayHigh": 1.55, "payoutRatio": 0.0, "beta": 1.026, "forwardPE": -0.10360962, "volume": 29661, "regularMarketVolume": 29661, "averageVolume": 1075125, "averageVolume10days": 91990, "averageDailyVolume10Day": 91990, "bid": 1.47, "ask": 1.57, "bidSize": 1, "askSize": 1, "marketCap": 4751835, "fiftyTwoWeekLow": 1.38, "fiftyTwoWeekHigh": 18.72, "priceToSalesTrailing12Months": 4.751835, "fiftyDayAverage": 1.6066, "twoHundredDayAverage": 5.62925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1290, "profitMargins": 0.0, "floatShares": 3007759, "sharesOutstanding": 3065700, "sharesShort": 79670, "sharesShortPriorMonth": 63365, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.025999999, "heldPercentInsiders": 0.01582, "heldPercentInstitutions": 0.030580001, "shortRatio": 0.51, "shortPercentOfFloat": 0.026199998, "impliedSharesOutstanding": 3065700, "bookValue": 1.342, "priceToBook": 1.1549925, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -9429429, "trailingEps": -10.45, "forwardEps": -14.96, "lastSplitFactor": "1:8", "lastSplitDate": 1727654400, "enterpriseToRevenue": 0.001, "enterpriseToEbitda": -0.0, "52WeekChange": -0.8981482, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 1.55, "targetHighPrice": 160.0, "targetLowPrice": 160.0, "targetMeanPrice": 160.0, "targetMedianPrice": 160.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 4861503, "totalCashPerShare": 1.586, "ebitda": -13407179, "totalDebt": 110957, "quickRatio": 1.771, "currentRatio": 2.154, "totalRevenue": 1000000, "debtToEquity": 2.749, "revenuePerShare": 0.959, "returnOnAssets": -1.33989, "returnOnEquity": -2.8535001, "grossProfits": -351390, "freeCashflow": -7877949, "operatingCashflow": -8426232, "revenueGrowth": 52.688, "grossMargins": -0.35139, "ebitdaMargins": 0.0, "operatingMargins": -2.8494198, "financialCurrency": "USD", "symbol": "SONN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Sonnet BioTherapeutics Holdings, Inc.", "hasPrePostMarketData": true, "postMarketPrice": 1.5016, "postMarketChange": -0.0483999, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.48 - 1.55", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1075125, "fiftyTwoWeekLowChange": 0.16999996, "fiftyTwoWeekLowChangePercent": 0.12318838, "fiftyTwoWeekRange": "1.38 - 18.72", "fiftyTwoWeekHighChange": -17.17, "fiftyTwoWeekHighChangePercent": -0.91720086, "fiftyTwoWeekChangePercent": -89.81482, "dividendDate": 1585785600, "earningsTimestamp": 1739451600, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -10.45, "epsForward": -14.96, "epsCurrentYear": -27.36, "priceEpsCurrentYear": -0.056652043, "corporateActions": [], "postMarketTime": 1740789078, "regularMarketTime": 1740776401, "exchange": "NCM", "messageBoardId": "finmb_410378138", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.64935005, "regularMarketPrice": 1.55, "shortName": "Sonnet BioTherapeutics Holdings", "firstTradeDateMilliseconds": 1162305000000, "postMarketChangePercent": -3.12258, "marketState": "CLOSED", "fiftyDayAverageChange": -0.056600094, "fiftyDayAverageChangePercent": -0.035229735, "twoHundredDayAverageChange": -4.0792503, "twoHundredDayAverageChangePercent": -0.7246525, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Sonnet BioTherapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]